Gaviscon and Estring drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate) and Estring (estradiol). Common drug interactions include angioedema among females.

The phase IV clinical study analyzes what interactions people have when they take Gaviscon and Estring. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Estring?

Estring has active ingredients of estradiol. eHealthMe is studying from 5,474 Estring users. Check the latest studies of Estring.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

17 people who take Gaviscon and Estring together, and have interactions are studied.

What are the common drug interactions of Gaviscon and Estring, by gender? *:

female:

Angioedema (rapid swelling of the dermis)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Emotional distress
General physical health deterioration (weak health status)
Gingival erythema (redness of gums)
Gingival swelling (gums swelling)
Gingival ulceration (ulcer on gums)
Hot flush (sudden feelings of heat)
Hypertension (high blood pressure)
Hypophagia (reduced food intake)

male:

n/a

What are the common drug interactions of Gaviscon and Estring, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Angioedema (rapid swelling of the dermis)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Emotional distress
General physical health deterioration (weak health status)
Gingival erythema (redness of gums)
Gingival swelling (gums swelling)
Gingival ulceration (ulcer on gums)
Hot flush (sudden feelings of heat)
Hypertension (high blood pressure)
Hypophagia (reduced food intake)

What are the existing conditions these people have? *

Hot Flush (sudden feelings of heat): 14 people, 82.35%
Breast Cancer: 14 people, 82.35%
Vitamin B12 Deficiency: 1 person, 5.88%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.88%
Pain: 1 person, 5.88%
Movement - Uncontrolled Or Slow: 1 person, 5.88%
Migraine (headache): 1 person, 5.88%
Ear Disorder: 1 person, 5.88%
Dizziness: 1 person, 5.88%
Blood Iron Increased: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and Estring?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously